- Home
- RAPP vs SIGA Comparison
RAPP vs SIGA Comparison
Compare RAPP & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPP
- SIGA
- Stock Information
- Founded
- RAPP 2022
- SIGA 1995
- Country
- RAPP United States
- SIGA United States
- Employees
- RAPP N/A
- SIGA 45
- Industry
- RAPP
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- RAPP
- SIGA Health Care
- Exchange
- RAPP Nasdaq
- SIGA Nasdaq
- Market Cap
- RAPP 439.4M
- SIGA 515.1M
- IPO Year
- RAPP 2024
- SIGA 1997
- Fundamental
- Price
- RAPP $15.40
- SIGA $6.86
- Analyst Decision
- RAPP Strong Buy
- SIGA
- Analyst Count
- RAPP 2
- SIGA 0
- Target Price
- RAPP $35.00
- SIGA N/A
- AVG Volume (30 Days)
- RAPP 170.4K
- SIGA 338.0K
- Earning Date
- RAPP 08-11-2025
- SIGA 08-05-2025
- Dividend Yield
- RAPP N/A
- SIGA 8.49%
- EPS Growth
- RAPP N/A
- SIGA N/A
- EPS
- RAPP N/A
- SIGA 0.67
- Revenue
- RAPP N/A
- SIGA $120,330,310.00
- Revenue This Year
- RAPP N/A
- SIGA N/A
- Revenue Next Year
- RAPP N/A
- SIGA $95.31
- P/E Ratio
- RAPP N/A
- SIGA $10.53
- Revenue Growth
- RAPP N/A
- SIGA N/A
- 52 Week Low
- RAPP $6.43
- SIGA $4.95
- 52 Week High
- RAPP $29.74
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- RAPP N/A
- SIGA 58.45
- Support Level
- RAPP N/A
- SIGA $6.97
- Resistance Level
- RAPP N/A
- SIGA $7.32
- Average True Range (ATR)
- RAPP 0.00
- SIGA 0.19
- MACD
- RAPP 0.00
- SIGA 0.01
- Stochastic Oscillator
- RAPP 0.00
- SIGA 56.94
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.